There is only one rational conclusion from examining all the data: COVID vaccines are both unsafe and ineffective. If the forces of evil pushing medical tyranny prevail, then a very dark vaccine dystopia probably awaits us.
In here we discuss the safety, toxicity and known side effects and drug interactions, few and mild as they are.
I felt this material needed to be brought out into the public to help assure we are having complete conversations founded on the latest data.
What does the most recent research say about the efficacy of COVID-19 vaccines? In this two-part episode, we sit down again with Dr. Malone for a comprehensive look at the vaccines, booster shots, repurposed drugs like ivermectin, and the ethics of vaccine mandates.
Now in part two, we take a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.
In here we discuss the safety, toxicity and known side effects and drug interactions, few and mild as they are.
I felt this material needed to be brought out into the public to help assure we are having complete conversations founded on the latest data.
In this Buffalo Hospital Room, a Grandmother Led the Global Fight for the Drug That Would Save Her Life and End the Pandemic
There is only one rational conclusion from examining all the data: COVID vaccines are both unsafe and ineffective. If the forces of evil pushing medical tyranny prevail, then a very dark vaccine dystopia probably awaits us.
Now in part two, we take a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.
What does the most recent research say about the efficacy of COVID-19 vaccines? In this two-part episode, we sit down again with Dr. Malone for a comprehensive look at the vaccines, booster shots, repurposed drugs like ivermectin, and the ethics of vaccine mandates.
The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19. Participants will receive either study drug or placebo. They will self-report any new or worsening symptoms or medical events they may experience while taking study drug or placebo. This study is intended to be all remote with no in person visits, unless the study team feels it is in the best interest of a participant to see them in person.
Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin’s antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the early stages of infection. Currently, evidence on ef�icacy and safety of ivermectin for prevention of SARS-CoV-2 infection and COVID-19 treatment is con�licting.
In this Buffalo Hospital Room, a Grandmother Led the Global Fight for the Drug That Would Save Her Life and End the Pandemic
After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.
